Calista Therapeutics: F508del Research

I was just looking through my blog and realised I have not posted about Calista here. Calista Therapeutics are developing medications that target F508del. Pre clinical studies are underway and they are looking for funding for a phase 2a trial. The lead candidate is Procaftor, which appears to work to about 116% of VX809 (see the graph). I've added more info and the graph here: http://sixtyfiverosesblog.wordpress....8del-research/
Source: Cystic Fibrosis CFTR Modulation and Gene Therapy Forum - Category: Respiratory Medicine Authors: Tags: CFTR Modulation and Gene Therapy Talk Source Type: forums